What does the product information say about breastfeeding during treatment with Myozyme (alglucosidase alfa)?

Breastfeeding during Myozyme (alglucosidase alfa) treatment may be considered because limited data suggest very low milk concentrations and no infant clinical effect is expected owing to low milk transfer and poor bioavailability, although interruption for the first 24 hours after treatment may be considered as a precaution.